Advertisement
Screener

PLx Pharma Winddown Corp. Repayments of Long-Term Debt

PLx Pharma Winddown Corp. Repayments of Long-Term Debt

PLx Pharma Winddown Corp. reported Repayments of Long-Term Debt of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.

Discontinued › Cash Flow › Financing Activities

us-gaap:RepaymentsOfLongTermDebt · last filed 2022-11-10

  • PLx Pharma Winddown Corp. repayments of long-term debt for the quarter ending 2022-09-30 was $0.00.
  • PLx Pharma Winddown Corp. repayments of long-term debt for the quarter ending 2022-06-30 was $0.00.
  • PLx Pharma Winddown Corp. repayments of long-term debt for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
  • PLx Pharma Winddown Corp. repayments of long-term debt for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
  • PLx Pharma Winddown Corp. repayments of long-term debt for fiscal 2021 was $625.00K, a 83.33% decline from fiscal 2020.
  • PLx Pharma Winddown Corp. repayments of long-term debt for fiscal 2020 was $3.75M, a 20.00% increase from fiscal 2019.
  • PLx Pharma Winddown Corp. repayments of long-term debt for fiscal 2019 was $3.13M.
Period endRepayments of Long-term Debt 3 monthRepayments of Long-term Debt 6 monthRepayments of Long-term Debt 9 monthRepayments of Long-term Debt 12 month
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$0.00
10-Q · filed 2022-11-10
$0.00
derived: sum of 4 quarters · filed 2022-11-10
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$0.00
10-Q · filed 2022-08-12
$0.00
derived: sum of 3 quarters · filed 2022-08-12
$0.00
derived: sum of 4 quarters · filed 2022-11-10
2022-03-31$0.00
10-Q · filed 2022-05-13
$0.00
derived: sum of 2 quarters · filed 2022-05-13
$0.00
derived: sum of 3 quarters · filed 2022-11-10
$0.00
derived: sum of 4 quarters · filed 2022-11-10
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$0.00
derived: sum of 3 quarters · filed 2022-11-10
$625.00K
10-K · filed 2022-03-11
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$625.00K
10-Q · filed 2022-11-10
$1.56M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$625.00K
10-Q · filed 2022-08-12
$1.56M
derived: sum of 3 quarters · filed 2022-08-12
$2.50M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$625.00K
10-Q · filed 2022-05-13
$1.56M
derived: sum of 2 quarters · filed 2022-05-13
$2.50M
derived: sum of 3 quarters · filed 2022-05-13
$3.44M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$937.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
$1.88M
derived: sum of 2 quarters · filed 2022-03-11
$2.81M
derived: sum of 3 quarters · filed 2022-03-11
$3.75M
10-K · filed 2022-03-11
2020-09-30$937.50K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$1.88M
derived: sum of 2 quarters · filed 2021-11-12
$2.81M
10-Q · filed 2021-11-12
$3.75M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$937.50K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$1.88M
10-Q · filed 2021-08-06
$2.81M
derived: sum of 3 quarters · filed 2021-08-06
2020-03-31$937.50K
10-Q · filed 2021-05-14
$1.88M
derived: sum of 2 quarters · filed 2021-05-14
2019-12-31$937.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$3.13M
10-K · filed 2021-03-12
2019-09-30$2.19M
10-Q · filed 2020-11-13